Array BioPharma, Inc. (ARRY)
|
3.77
-0.08 (-2.08%)
|
|
|
|
ARRY analyst ratings
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
ARRY price and earnings targets
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
Special Offers
ARRY earnings
Date
Actual
Expected
Prev Yr Qtr
8/13/2012
-0.09
-0.13
-0.17
4/30/2012
-0.11
-0.16
-0.20
1/30/2012
-0.06
-0.12
-0.23
Array BioPharma, Inc. (ARRY) Upgrades
Date
Analyst
Old Rating
New Rating
07/23/2010
Update - UBS
Neutral
Buy PT $ 425
07/23/2010
UBS
Neutral
Buy PT $ 425
11/05/2009
UBS
Neutral
Buy
Array BioPharma, Inc. (ARRY) Downgrades
Date
Analyst
Old Rating
New Rating
09/08/2009
UBS
Buy
Neutral
09/04/2009
Leerink Swann
Outperform
Market Perform
09/04/2009
Baird
Buy
Neutral
Array BioPharma, Inc. (ARRY) New Coverage
Date
Analyst
Rating
10/21/2008
Susquehanna
Positive
02/07/2008
William Blair
Outperform
12/04/2007
Morgan Joseph
Buy
10/09/2007
Lehman Brothers
Overweight
